HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

2,3,6-trimethyl-1,4-naphthoquinone

isolated from tobacco; structure in first source

Also Known As:

TM-NQ cpd

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Hydrocarbons: 1713
  - Cyclic Hydrocarbons: 97
    - Aromatic Hydrocarbons: 291
      - Polycyclic Aromatic Hydrocarbons: 2020
        Naphthalenes: 18
        Naphthoquinones: 418
        2,3,6-trimethyl-1,4-naphthoquinone: 1
- Quinones: 434
  - Naphthoquinones: 418
    - 2,3,6-trimethyl-1,4-naphthoquinone: 1
Polycyclic Compounds: 6
- Polycyclic Aromatic Hydrocarbons: 2020
  - Naphthalenes: 18
    - Naphthoquinones: 418
      - 2,3,6-trimethyl-1,4-naphthoquinone: 1

Experts

1.	Castagnoli, K: 1 article (01/2003)
2.	Castagnoli, N: 1 article (01/2003)
3.	Petzer, J B: 1 article (01/2003)
4.	Steyn, S J: 1 article (01/2003)
5.	van der Schyf, C J: 1 article (01/2003)

Related Diseases

1.

Parkinson Disease (Parkinson's Disease)

01/01/2003 - "Prompted by the findings that smokers have lowered brain and blood platelet monoamine oxidase-A and -B activities compared to non-smokers and that smokers have a lowered incidence of Parkinson's disease, we have examined the neuroprotective properties of an MAO inhibitor, 2,3,6-trimethyl-1,4-naphthoquinone (TMN), which is present in the tobacco plant and smoke in the MPTP C57BL/6 mouse model of neurodegeneration. "

Related Drugs and Biologics

1.	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)
2.	Smoke
3.	Monoamine Oxidase Inhibitors (Monoamine Oxidase Inhibitor)
4.	Monoamine Oxidase (MAO)